H. Fattaey

发表

CeReS‐18 inhibits growth and induces apoptosis in human prostatic cancer cells

T. Johnson, H. Fattaey, T. M. Quinton, 1999, The Prostate.

Purification and stability characterization of a cell regulatory sialoglgycopeptide inhibitor

P. Moos, T. Johnson, H. Fattaey, 1995, Journal of cellular biochemistry.

Calcium influences sensitivity to growth inhibition induced by a cell surface sialoglycopeptide

N. Betz, T. Johnson, H. Fattaey, 1994, Journal of cellular physiology.

Inhibition of cyclin D-cdk activity in cell cycle arrest of Swiss 3T3 cells by CeReS-18, a novel cell regulatory sialoglycopeptide.

T. Johnson, H. Fattaey, T. M. Quinton, 1998, Experimental cell research.

Cell proliferation inhibition in reduced gravity.

P. Moos, T. Johnson, H. Fattaey, 1994, Experimental cell research.

A cell stabilization factor for transport of experimental cell cultures to and from the International Space Station

R. Consigli, T. Johnson, H. Fattaey, 2001 .

Inhibition of DNA synthesis and cell division by a cell surface sialoglycopeptide

T. Johnson, H. Fattaey, H. H. Chou, 1989, Journal of cellular physiology.

Effects of a sialoglycopeptide on early events associated with signal transduction

T. Johnson, H. Fattaey, W. Toole-Simms, 1991, Journal of cellular physiology.

Relationship between protease activity and a sialoglycopeptide inhibitor isolated from bovine brain

T. Johnson, B. Sharifi, C. Bascom, 1986, Journal of cellular biochemistry.

Murine polyomavirus infection of 3T6 mouse cells shows evidence of predominant necrosis as well as limited apoptosis.

R. Consigli, H. Fattaey, A. Paulsen, 2000, Virus research.

Modulation of growth-related gene expression and cell cycle synchronization by a sialoglycopeptide inhibitor.

T. Johnson, C. Bascom, H. Fattaey, 1991, Experimental cell research.

CeReS-18, a novel cell surface sialoglycopeptide, induces cell cycle arrest and apoptosis in a calcium-sensitive manner

N. Betz, T. Johnson, H. Fattaey, 2004, Breast Cancer Research and Treatment.

Inhibition of hormone and growth factor responsive and resistant human breast cancer cells by CeReS-18, a cell regulatory sialoglycopeptide

P. Moos, N. Betz, T. Johnson, 2004, Breast Cancer Research and Treatment.

CeReS-18, a cell regulatory sialoglycopeptide, inhibits proliferation and migration of rat vascular smooth muscle cells.

T. Johnson, H. Fattaey, K. Zhao, 2000, Experimental cell research.

Cell cycle arrest and cellular differentiation mediated by a cell surface sialoglycopeptide.

T. Johnson, H. Fattaey, G. Edson, 1991, Life Science.

The identification of a naturally occurring cell surface growth inhibitor related to a previously described bovine sialoglycopeptide

P. Moos, T. Johnson, H. Fattaey, 1993, Journal of cellular biochemistry.

Model system for studies on bone matrix formation by osteogenic cells in microgravity

T. Johnson, H. Fattaey, T. M. Quinton, 2008 .

Growth inhibition of BALB/c mouse keratinocytes by TGF-beta 1 and CeReS-18 appears to act through distinct mechanisms.

N. Betz, T. Johnson, H. Fattaey, 1996, Experimental cell research.

The stabilization of cell proliferation and its reversal in the microgravity environment

T. Johnson, H. Fattaey, 1997 .

Selective cytotoxicity of transformed cells but not normal cells by a sialoglycopeptide growth regulator in the presence of tumor necrosis factor.

S. Chapes, T. Johnson, K. Woods, 1994, Biochemical and biophysical research communications.